Diseases

Pfizer plans to seek authorization for Covid-19 vaccine in November: company

Pfizer plans to seek authorization for Covid-19 vaccine in November: company

Pfizer plans to seek authorization for Covid-19 vaccine in November: company

vaccine
Credit: Unsplash/CC0 Public Domain

US pharmaceutical giant Pfizer expects to file for emergency use authorization for its COVID-19 vaccine in late November, around two weeks after the November 3 US presidential election, it said Friday.

The company said it hopes to move ahead with the vaccine after safety data is available in the third week of November, immediately lifting the company’s shares two percent in the US.

“So let me be clear, assuming positive data, Pfizer will apply for Emergency Authorization Use in the US soon after the safety milestone is achieved in the third week of November,” the company‘s chairman and CEO Albert Bourla said in an open letter.


Follow the latest news on the coronavirus (COVID-19) outbreak


© 2020 AFP

Citation:
Pfizer plans to seek authorization for Covid-19 vaccine in November: company (2020, October 16)
retrieved 16 October 2020
from https://medicalxpress.com/news/2020-10-pfizer-authorization-covid-vaccine-november.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


https://medicalxpress.com/news/2020-10-pfizer-authorization-covid-vaccine-november.html

Related Articles

Back to top button